GlassScriptPhysician profile
Brittany M Murray
NPI 1346682556
$140,877.34
in general payments reported to CMS, 2019-2025
10 companies · $49K in 2025
The $49K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17K · 2022: $39K · 2023: $23K · 2024: $13K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42K · Travel and Lodging: $23K · Consulting Fee: $9,587 · Food and Beverage: $6,337 · Honoraria: $3,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42,102.50 |
| Travel and Lodging | $23,434.53 |
| Consulting Fee | $9,586.78 |
| Food and Beverage | $6,336.61 |
| Honoraria | $3,469.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $113,033.10 | 2021-2025 | Palynziq |
| Horizon Therapeutics Plc | $17,936.70 | 2021-2023 | Ravicti |
| Ptc Therapeutics, INC. | $4,852.35 | 2021-2025 | Sephience |
| Cycle Pharmaceuticals INC | $1,620.00 | 2021-2022 | |
| Zevra Therapeutics INC | $1,443.04 | 2024-2025 | Olpruva |
| Eton Pharmaceuticals, INC. | $875.00 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $793.04 | 2021-2023 | Dojolvi |
| Chiesi USA, INC. | $115.38 | 2025 | Elfabrio |
| Alexion Pharmaceuticals, INC. | $108.38 | 2023 | Koselugo |
| Genzyme Corporation | $100.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.